Natco Pharma reports multifold rise in net profit to Rs 320.4 crore in Q1

Published On 2022-08-12 04:00 GMT   |   Update On 2022-08-12 04:01 GMT
Advertisement

New Delhi: Natco Pharma Ltd on Tuesday reported a multifold rise in consolidated net profit to Rs 320.4 crore for the first quarter ended June 30, on higher revenue from the pharmaceutical vertical. The company had posted a consolidated net profit of Rs 75 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.

Its consolidated revenue from operations during the quarter under review stood at Rs 884.6 crore compared to Rs 410.3 crore in the same period last fiscal, it added.
Advertisement
The pharmaceutical segment revenue increased to Rs 883.6 crore from Rs 409.7 crore in the first quarter of last year. This was inclusive of an income from the settlement of claims received by the company's arm Natco Pharma (Canada) Inc under a settlement agreement.
"During the quarter, export sales of Lenalidomide product to the US was a major contributor to the revenue and profitability of the business," Natco said, adding domestic formulations business remained steady.
Agrochemicals vertical registered revenue of Rs 1 crore, up from Rs 60 lakh in the year-ago quarter, the company said.  
The total expenses in the first quarter were higher at Rs 533.1 crore against Rs 336.3 crore a year ago. There was a one-time cost associated with retirement schemes during the quarter and higher than usual R&D costs for product development, it added. 
The company paid compensation totalling Rs 29.1 crore under the voluntary retirement scheme during the quarter ended June 30, 2022, Natco said.
The board of directors of the company has also approved an interim dividend of Rs 3.50 each per equity share of Rs 2 each for the financial year 2022-23, the filing said.

Read also: Eyestem raises Rs 51 crore in Series A round led by Biological E, Alkem, Natco and others 

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News